US Physical Therapy/$USPH
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1Y5YMAX
About US Physical Therapy
US Physical Therapy Inc through its subsidiaries operates outpatient physical therapy clinics that provide pre-and post-operative care and treatment for orthopedic-related disorders, sports-related injuries, preventative care, rehabilitation of injured workers, and neurological-related injuries. The principal payment sources for the clinics' services are managed care programs, commercial health insurance, Medicare/Medicaid, workers' compensation insurance, and proceeds from personal injury cases. Its operating segment includes Physical therapy operations and Industrial injury prevention services. The company generates maximum revenue from the Physical therapy operations segment.
Ticker
$USPH
Sector
Primary listing
NYSE
Employees
5,531
Headquarters
Website
USPH Metrics
BasicAdvanced
$1.2B
34.30
$2.29
1.46
$1.79
2.29%
Price and volume
Market cap
$1.2B
Beta
1.46
52-week high
$98.86
52-week low
$62.77
Average daily volume
155K
Dividend rate
$1.79
Financial strength
Current ratio
1.183
Quick ratio
1.073
Long term debt to equity
33.463
Total debt to equity
39.891
Dividend payout ratio (TTM)
70.63%
Interest coverage (TTM)
8.51%
Profitability
EBITDA (TTM)
96.655
Gross margin (TTM)
22.05%
Net profit margin (TTM)
5.28%
Operating margin (TTM)
10.34%
Effective tax rate (TTM)
24.32%
Revenue per employee (TTM)
$130,000
Management effectiveness
Return on assets (TTM)
4.24%
Return on equity (TTM)
7.45%
Valuation
Price to earnings (TTM)
34.303
Price to revenue (TTM)
1.643
Price to book
2.38
Price to tangible book (TTM)
-3.38
Price to free cash flow (TTM)
19.489
Free cash flow yield (TTM)
5.13%
Free cash flow per share (TTM)
4.025
Dividend yield (TTM)
2.28%
Forward dividend yield
2.29%
Growth
Revenue change (TTM)
16.25%
Earnings per share change (TTM)
116.39%
3-year revenue growth (CAGR)
11.39%
10-year revenue growth (CAGR)
8.70%
3-year earnings per share growth (CAGR)
-7.88%
10-year earnings per share growth (CAGR)
3.33%
3-year dividend per share growth (CAGR)
4.05%
10-year dividend per share growth (CAGR)
12.67%
What the Analysts think about USPH
Analyst ratings (Buy, Hold, Sell) for US Physical Therapy stock.
Bulls say / Bears say
Physical therapy operations revenue rose 17.3% year-over-year to $168.3 million in Q2 2025, driven by a record 1.56 million patient visits. (Reuters)
Adjusted EBITDA for Q2 2025 beat analyst expectations, rising 21.4% to $26.9 million and reflecting strong operational leverage. (Reuters)
The company raised its full-year 2025 Adjusted EBITDA guidance to $93.0 million–$97.0 million, underscoring management’s confidence in its growth trajectory. (Reuters)
Revenue from mature clinics grew only 0.2% year-over-year in Q2 2025, indicating limited organic growth in established locations. (Nasdaq)
Interest expense rose 20% year-over-year to $2.4 million in Q2 2025 as the all-in cost of borrowings climbed to 5.6%, squeezing net income. (Nasdaq)
Management noted that staffing remains tight and macroeconomic uncertainty could dampen demand for outpatient therapy services. (Finviz)
Data summarised monthly by Lightyear AI. Last updated on 4 Sept 2025.
USPH Financial Performance
Revenues and expenses
USPH Earnings Performance
Company profitability
USPH News
AllArticlesVideos
U.S. Physical Therapy Reports Second Quarter 2025 Results
Business Wire1 month ago
U.S. Physical Therapy Announces the Acquisition of a Three-Clinic Physical Therapy Practice
Business Wire2 months ago
U.S. Physical Therapy, Inc. Schedules Second Quarter 2025 Earnings Release and Conference Call Dates
Business Wire2 months ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
Capital at risk
Upcoming events
No upcoming events
FAQs
What’s the current market cap for US Physical Therapy stock?
US Physical Therapy (USPH) has a market cap of $1.2B as of September 18, 2025.
What is the P/E ratio for US Physical Therapy stock?
The price to earnings (P/E) ratio for US Physical Therapy (USPH) stock is 34.3 as of September 18, 2025.
Does US Physical Therapy stock pay dividends?
Yes, the US Physical Therapy (USPH) stock pays dividends to shareholders. As of September 18, 2025, the dividend rate is $1.79 and the yield is 2.29%. US Physical Therapy has a payout ratio of 70.63% on a trailing twelve-month basis.
When is the next US Physical Therapy dividend payment date?
The next US Physical Therapy (USPH) dividend payment date is unconfirmed.
What is the beta indicator for US Physical Therapy?
US Physical Therapy (USPH) has a beta rating of 1.46. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.